Effect of a Self-care Intervention on Depression in People With Age-related Macular Degeneration or Diabetic Retinopathy

Maisonneuve-Rosemont Hospital80 enrolled

Overview

The purpose of this trial is to determine the short-term effect of a self-care intervention on depression in patients with age-related macular degeneration or diabetic retinopathy.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Depression Age-related Macular Degeneration

Interventions

Self-Care ToolsBEHAVIORAL

Eligibility

Sex: ALLMin age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * clinical diagnosis of wet or dry AMD or diabetic retinopathy * age 50 years and older * at least mild depressive symptoms (a score of 5 or more on the PHQ-9) * no legal blindness (visual acuity better than 20/200 in better eye). Exclusion Criteria: * the current use of cognitive behavioural therapy * suicidal intent * ocular surgery during the study period (intravitreal anti-VEGF injections will be allowed, e.g. Lucentis) * cognitive impairment * inability to speak and understand French or English * profound hearing impairment.

Locations (1)

Maisonneuve-Rosemont Hospital

Montreal, Quebec, Canada

Outcomes

Primary Outcomes

Change in depressive symptoms

Depressive symptoms will be measured by the PHQ-9, a validated 9 item instrument.

Time frame: Baseline and 8 weeks

Secondary Outcomes

Change in severity of anxiety symptoms

The GAD-7 can be used to establish probable diagnoses of generalized anxiety disorder as well as grade its severity (mild, moderate and severe).

Time frame: Baseline and 8 weeks

Change in self-efficacy

Self-efficacy will be measured with a 4-item scale, adapted from a validated diabetes self-care self-efficacy scale. Scores range from 0-12.

Time frame: Baseline and 8 weeks

Change in life space

The Life Space Assessment asks about the spatial extent in which the participant has traveled over the last month. Scores range from 0-100.

Time frame: Baseline and 8 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.